Bon Natural Life Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $18.7M-21.7% YoYTTM through 30 Sep 2025
Net Income -$2M-601.0% YoYTTM through 30 Sep 2025
Free Cash Flow $134.3KTTM through 30 Sep 2025
Margins
| Current | |
|---|---|
| Gross Margin | 20.8% |
| EBITDA Margin | -2.9% |
| Operating Margin | -8.7% |
| Net Margin | -10.7% |
Returns
-3.5%ROE
-2.4%ROA
Balance Sheet Health
Debt / Equity0.21x
Current Ratio1.74x
Net Debt$8.7M
Cash & Equivalents$6.3M
Quality Metrics
Altman Z-Score0.98
Piotroski F-Score3 / 9
FCF Margin0.7%
Multi-Year Trend
RevenueFY2025: $18.7M
Diluted EPS-$0.72TTMFY2025: $-0.72
Dividend
No dividend
Capital Allocation
R&D Spend$754.2K
Capex Intensity0.0%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Fragrance compounds | $8.1M | View detailsRemains the largest revenue contributor, primarily driven by natural compounds extracted from plants for cosmetic applications. | |
| Bioactive food ingredients | $7.3M | View detailsSecond largest segment, facing some volume pressure due to product transitions. | |
| Health supplements (solid drinks) | $3.3M | View detailsSmallest segment, impacted by declining market demand in the powder drink consumer market. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.